Skip to content

Detection of circulating tumor DNA genome andcytokines in patients with advanced lung cancer

Detection of circulating tumor DNA genome andcytokines in patients with advanced lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-POC-15007228
Enrollment
Unknown
Registered
2015-10-17
Start date
2015-10-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Case series:Nil

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age over 18; 2. lung cancer confirmed by pathology; 3. Eastern Cooperative Oncology Group score 0-1; 4. Neutrophils >=1500/uL, platelet>=100,000/uL; 5. Tumor stage was IV according to the seventh edition of the American Joint Committee on Cancer Cancer Staging Manual; 6. patients didnt undergo chemotherapy or radiotherapy; 7. Patients received the gemcitabine plus platinum chemotherapy (no more than six cycles).

Exclusion criteria

Exclusion criteria: 1. serious uncontrolled infections; 2. Albumin level < 30g/L; 3. Pregnancy, or patients with other malignant tumors, or digestive disease affecting drug absorption; 4. Patients refused entry into the group; 5. Patients received with maintain treated.

Design outcomes

Primary

MeasureTime frame
cytokines;ctDNA genome;

Countries

China

Contacts

Public ContactZhenyu Ding
dingzy3333@163.com+86 18980601957

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026